FIELD: organic chemistry, amino acids, pharmacy.
SUBSTANCE: invention relates to derivatives of β-alanine of the general formula (I):
wherein Q1 or Q3 mean CH or nitrogen atom (N) independently of one another but they can't mean simultaneously nitrogen atom (N); R1 represents hydrogen atom (H), A, Ar or Hal; R2 means hydrogen atom (H) or A; R3 means
,or;
each among R4 and R5 means independently hydrogen atom (H), A or Hal; R6 represents hydrogen atom (H) or A; A represents alkyl with 1-6 carbon atoms; Ar represents unsubstituted aryl; Hal means fluorine (F), chlorine (Cl), bromine (Br) or iodine (J) atom; n = 2, 3, 4, 5 or 6; m = 1, 2, 3 or 4, and to their physiologically acceptable salts or solvates also, and to methods for their preparing and to a pharmaceutical preparation eliciting property of inhibitor of integrins.
EFFECT: improved preparing method, valuable biological and medicinal properties of compounds.
7 cl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF INDOLE-3-YL | 2001 |
|
RU2257380C2 |
INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3 | 2013 |
|
RU2623441C2 |
ANTAGONISTS OF ALPHAVBETA3 AND ALPHAVBETA6 INTEGRINS AND ANTIFIBROTIC AGENTS | 2004 |
|
RU2388472C2 |
NOVEL ANTIOGENESIS INHIBITING COMPOUNDS AND USE THEREOF | 2005 |
|
RU2393154C2 |
NEW DERIVATIVES OF CYCLOUREA, PRODUCTION AND PHARMACEUTICAL APPLICATION AS KINASE INHIBITORS | 2004 |
|
RU2341523C2 |
DERIVATIVES OF HYDRAZONE-PYRAOLE AND MEDICAL APPLICATION THEIROF | 2002 |
|
RU2332996C2 |
SUBSTITUTED ANILIDES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT | 1998 |
|
RU2233269C2 |
INHIBITORS OF INTEGRIN FOR TREATING OCULAR DISEASES | 2002 |
|
RU2311177C2 |
DERIVATIVES OF UREA, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296120C2 |
NEW AMINOPYRIDIN DERIVATIVE WITH INHIBITION ACTIVITY IN RELATION TO SYK | 2006 |
|
RU2363699C2 |
Authors
Dates
2004-08-20—Published
2000-02-08—Filed